Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. Recherche
  • icone plus

  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte

  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités

2 results

  • Language : Français
  • Producer : inconnu
  • Topics : Genital cancers
Filter
Topic
  • Economics and public health (2)
  • Plus ...
    • Health economics (2)
    • Screening, prevention (2)
  • Diagnostic and therapeutic techniques (2)
  • Plus ...
    • Diagnostic techniques and procedures (2)
    • Plus ...
      • Biology (laboratory tests) (2)
  • Diseases and conditions (2)
  • Plus ...
    • Genital diseases (2)
    • Plus ...
      • Genital cancers (2)
      • Female genital diseases (1)
    • Infectious diseases (1)
    • Plus ...
      • Sexually transmitted diseases (1)
      • Virus diseases (1)
Content type
  • Practice Guidelines and Other Guides (2)
  • Plus ...
    • Public Health guideline (2)
Fabricant
  • alter (1)
  • inconnu (2)
Langue
  • Français (2)
Substance active
  • argent (1)
  • iode (1)
More filter Other Filter Icon
Search Export

Practice guidelines and other guides - 2 results

  • Evaluation of human papillomavirus (HPV) tests for primary screening of precancerous and cancerous lesions of the cervix and the role of p16/Ki67 dual immunostaining

    Public Health guideline - Posted on 11/7/2019
    Download abstract
    Add to my selection

  • Appropriateness of systematic screening for prostatic cancer by prostate specific antigen (PSA)

    Public Health guideline - Posted on 1/1/1999 - Mis à jour le 6/12/2006
    Download abstract
    Add to my selection

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
wAJfKg3LgTFZ3Ran